Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study

被引：0

作者：

Feist, Eugen ^{[1
]}

Nasonov, Evgeny ^{[2
]}

Luggen, Michael ^{[3
]}

Fatenejad, Saeed ^{[4
]}

Grishin, Sergey ^{[5
]}

Samsonov, Mikhail ^{[6
]}

Fleischmann, Roy ^{[7
,8
]}

机构：

[1] Otto von Guericke Univ, Helios Clin VogelsangGommern, Magdeburg, Germany

[2] VA Nasonova Res Inst Rheumatol, Moscow, Russia

[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[4] SFC Med LLC, Charlotte, NC USA

[5] R Pharm, Moscow, Russia

[6] R Pharm JSC, Moscow, Russia

[7] Univ Texas SouthWestern Med Ctr, Dallas, TX USA

[8] Metroplex Clin Res Ctr, Dallas, TX USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0309

引用

页码：603 / 606

页数：4

共 2 条

[1] LONG-TERM SAFETY AND EFFICACY OF OLOKIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS - RESULT OF AN OPEN-LABEL EXTENSION STUDY, CREDO4 [J].

Feist, E. ;

Nasonov, E. ;

Luggen, M. ;

Fatenejad, S. ;

Grishin, S. ;

Samsonov, M. ;

Fleischmann, R. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :593-593

[2] Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study [J].

Nasonov, Evgeniy ;

Fatenejad, Saeed ;

Feist, Eugen ;

Ivanova, Mariana ;

Korneva, Elena ;

Krechikova, Diana G. ;

Maslyanskiy, Aleksey L. ;

Samsonov, Mikhail ;

Stoilov, Rumen ;

Zonova, Elena, V ;

Genovese, Mark .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (04) :469-479

← 1 →